Table 3 Univariate Cox analysis for key genes
From: Prognostic significance of SNCA and its methylation in bladder cancer
Characteristics | Total(N) | Univariate analysis | |
|---|---|---|---|
Hazard ratio (95% CI) | P value | ||
ADGRL4 (Low vs. High) | 407 | 0.709 (0.527–0.955) | 0.024 |
ANGPTL1 (Low vs. High) | 407 | 0.694 (0.515–0.935) | 0.016 |
CDH5 (Low vs. High) | 407 | 0.789 (0.587–1.060) | 0.116 |
CNN1 (Low vs. High) | 407 | 0.727 (0.539–0.981) | 0.037 |
CNTN1 (Low vs. High) | 407 | 0.672 (0.497–0.907) | 0.009 |
DACT3 (Low vs. High) | 407 | 0.658 (0.487–0.890) | 0.007 |
DIPK2B (Low vs. High) | 407 | 0.722 (0.537–0.970) | 0.031 |
BMX (Low vs. High) | 407 | 0.712 (0.530–0.957) | 0.024 |
F13A1 (Low vs. High) | 407 | 0.691 (0.513–0.931) | 0.015 |
KCNH2 (Low vs. High) | 407 | 0.902 (0.672–1.211) | 0.493 |
KCNMB1 (Low vs. High) | 407 | 0.790 (0.587–1.064) | 0.121 |
LMOD1 (Low vs. High) | 407 | 0.690 (0.512–0.930) | 0.015 |
MMP9 (Low vs. High) | 407 | 0.707 (0.525–0.952) | 0.022 |
MYLK (Low vs. High) | 407 | 0.577 (0.426–0.782) | < 0.001 |
PDE2A (Low vs. High) | 407 | 0.632 (0.469–0.850) | 0.002 |
PDE5A (Low vs. High) | 407 | 0.774 (0.574–1.044) | 0.093 |
RBM24 (Low vs. High) | 407 | 0.668 (0.496–0.900) | 0.008 |
ST6GALNAC3 (Low vs. High) | 407 | 0.642 (0.477–0.865) | 0.004 |
TAP2 (Low vs. High) | 407 | 0.920 (0.685–1.236) | 0.580 |
WNT5B (Low vs. High) | 407 | 0.704 (0.523–0.948) | 0.021 |